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This retrospective study analysed the diagnostic yield of single-site, two-site, and three-site anatomical
surveillance cultures in a population of 4,769 patients at high risk for methicillin-resistant Staphylococcus aureus
(MRSA) colonisation. Cultures of seven anatomical sites were used as the gold standard against which to
measure the sensitivity of MRSA detection. Detection rates for the seven single-sites, 21 two-site, and 35 three-
site combinations are presented. Single-site swabbing only detected 50.5% (nose) of total cases, while three-site
surveillance achieved a 92% (groinnosethroat) sensitivity of detection at best. It is recommended that at
least three anatomical sites should be screened for MRSA colonisation in these high-risk patients.
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I
nfections arising from methicillin-resistant Staphylo-
coccus aureus (MRSA) are an important cause of
healthcare-associated infections (HCAI) throughout
the world. They are associated with an increase in mor-
bidity, mortality, and an increase in healthcare costs and
there are indications that MRSA infections are increasing
worldwide (1). Individuals colonised with MRSA are at a
greater risk of developing infections with this organism
(2). The aim of this retrospective study was to determine
the optimal body sites and combinations of sites for de-
tection of MRSA carriage in a high-risk population using
sampling from seven anatomical sites as a gold standard.
Single-site swabbing has a low sensitivity of detection des-
pite it being recommended in some guidelines (3). Using
culture on selective media, we determined the sensitivity
of a single anatomical site sampling in this high-risk po-
pulation as well as all possible combinations of two and
three anatomical sites to find the highest detection rates.
Materials and methods
Between January 1 2010 and November 30 2012, 4,769
sets of body swabs were taken from adult patients
admitted to the Abertawe Bro-Morgannwg University
Hospital in Swansea, Wales. The body sites swabbed in all
patients were as follows: axilla, hairline, groin, nose,
perineum, throat, and umbilicus. Only patients where all
these anatomical sites were swabbed simultaneously were
accepted to this retrospective study. These were adult
patients who were classed as being at high risk for MRSA
colonisation because of their frequent re-admissions to
healthcare facilities; direct inter-hospital transfers; recent
admissions at a hospital known or likely to have a high
prevalence of MRSA; residents of nursing or residential
care homes; patients being admitted to high-risk areas;
transfers from outside the United Kingdom, or patients
with a history of colonisation with MRSA in the past.
Upon admission, swabs were taken from the above-
mentioned body sites, transported in charcoal transport
medium (Amies) and plated separately onto chromogenic
MRSA medium (P&O Laboratories). Suspect colonies
were subcultured onto Columbia blood agar (Oxoid Ltd)
and identified with a latex agglutination kit (Pro-Lab)
and each new isolate further tested on panel PMIC/ID-
67 of the Becton-Dickenson Phoenix ID system for
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confirmation of identity and provision of an antimicro-
bial susceptibility profile. S. aureus isolates were also
identified using mass spectrometry, MALDI-TOF (Bru-
ker) (4, 5). Patients were considered colonised if MRSA
was grown from any of the body sites tested. The seven-
site body screen was regarded as the reference standard
against which the sensitivity of single and combined
swabs was measured.
Statistics
The number of different combinations for the two-site
and the three-site determinations were calculated to be
seven for the single-site swabs, 21 for the two-site swabs,
and 35 for the three-site swabs. Confidence intervals were
calculated using the normal approximation method of the
binomial confidence interval.
Ethical approval was deemed unnecessary by the local
ethics committee, as this was a retrospective study.
Results
The number of seven-site anatomical sampling screens
taken from 4,769 individuals that detected MRSA was
925 (19.4%). The patient was considered colonised with
MRSA if any one of the swabs was found positive for
MRSA. Single-site swabs detected MRSA colonisation at
rates between 18% (hairline) and 50.5% (nose) as shown
in Table 1. The ability of two anatomical site swabs to
improve the detection of MRSA colonisation was deter-
mined by using all possible combinations from the
original set of seven sites sampled. There were 21
combinations possible and these are shown in Table 1.
The two-site swabs improved the detection rate of MRSA
by up to 50% with the best combination being the groin
and throat where 74.5% of colonisations were detected.
These were closely followed by the groin/nose, nose/
perineum, and the nose/throat combinations. Of note is
that some of the two-swab combinations, such as the
axilla/hairline and the hairline/umbilicus combinations,
had poorer detection rates than single swabs of the nose,
groin, perineum, or throat. However, 14 other two-site
combinations were more sensitive at detecting MRSA
colonisation than the single nasal swab (Table 1).
Three anatomical site combinations yielded even better
results than the two-site anatomical combinations when
compared to the seven-site anatomical gold standard.
Table 1 shows all 35 different combinations of three
anatomical site sampling with the best detection rate
accounted for by a combination of groinnosethroat,
which detected 92% of colonisations closely followed by
perineumnosethroat combinations (91%). It can be
noted from Table 1 that all but one of the triple-site
sampling had detection rates superior to that of the single
nose swab. The only combination with inferior results was
the axillahairlineumbilicus combination. Sampling
of the groin and throat together improved MRSA
detection by 47% and sampling of the groin, nose and
throat together improved MRSA detection by 82% when
compared to single-site sampling from the nose.
Discussion
In this study, we assessed the role of MRSA screening in
patients at high risk for MRSA colonisation. Sampling
from seven anatomic body sites was used as the reference
gold standard against which to measure single-site, two-
site, and three-site sampling combinations. This was to
determine the smallest combination of surface body sites
that can give the highest detection rates of MRSA
colonisation. Colonisation with MRSA is associated
with an increased likelihood of clinical infection with
MRSA (6). Screening patients for MRSA has been
advocated to detect carriers and enforce decolonisation
procedures which can reduce infections and prevent
transmission to others. Different countries have differing
policies on the screening procedures. US guidelines suggest
only that nasal swabbing may be sufficient (3), whereas
many in the United Kingdom recommend at least two sites
for screening (7, 8). In areas of low endemicity, single-site
screening may be sufficient to detect colonisation. How-
ever, in patients at high risk for MRSA colonisation, the
single-site nasal swab is likely to miss a significant number
of colonisations and allow spread of the organism in
healthcare establishments hence putting patients at risk of
developing infections with MRSA. In this study, we found
that swabs of the anterior nares alone detected only about
half (50.5%) of all possible cases whereas a triple swab
combination of nose, groin, and throat detected 92% of
colonisations. This contrasts with the Scottish results
where swabs of the nares detected 66.4% of MRSA
colonisations (9). Throat swabs alone performed less well
(10). Table 1 shows the results of two-site swabbing,
whereby groin and throat combinations improved sensi-
tivity of detection to 74.5%. It can also be seen that 10 of
the 21 two-site combinations gave superior results to the
nose swab alone. Certain anatomical site combinations
lacked sensitivity and gave poor results. Axilla, hairline,
and umbilicus combinations could not achieve the sensi-
tivity of single nose or throat swabs (Table 1). However,
triple swab combinations of most sites were as sensitive as
or of higher sensitivity than nasal, throat, or groin swabs
individually. From Table 1, it can be seen that only one of
the 35 different combinations failed to achieve the
sensitivity of the single nasal swab. Optimal two-site
screening is likely to miss up to 25% of MRSA colonisa-
tions. This study is unique in that it calculates all of the
different combinations of anatomic sites including all 21
possible two-site and all 35 three-site combinations. This
allows clinicians to predict the relative accuracy of
combination swab results in relation to the commonly
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Table 1. Numbers of MRSA colonisations detected at different anatomical sites and combinations of two and three sites
Anatomical site No. of patients MRSA detected (total925) Sensitivity (%) of detection (95% CI)
Single-site
Nose 467 50.5% (47.353.7)
Throat 444 48% (44.851.2)
Groin 408 44.2% (40.947.3)
Perineum 365 39.5% (36.342.6)
Umbilicus 214 23.1% (20.425.9)
Axilla 171 18.5% (1621)
Hairline 167 18% (15.620.5)
Two-site
Grointhroat 689 74.5% (71.777.3)
Groinnose 667 72.1% (69.275)
Noseperineum 664 71.8% (68.974.7)
Nosethroat 662 71.6% (68.774.5)
Perineumthroat 582 63% (59.866)
Throatumbilicus 553 59.8% (56.662.9)
Noseumbilicus 549 59.35% (56.262.5)
Axillanose 524 56.6% (53.559.8)
Axillathroat 521 56.3% (53.159.5)
Groinperineum 518 56% (52.859.2)
Hairlinethroat 513 55.46% (52.358.7)
Hairlinenose 501 54.1% (5157.4)
Groinumbilicus 482 52.1% (48.955.3)
Groinhairline 476 51.45% (48.254.7)
Axillagroin 457 49.4% (46.252.6)
Perineumumbilicus 455 49.2% (4652.4)
Axillaperineum 435 47% (43.850.2)
Hairlineperineum 432 46.7% (43.549.9)
Axillaumbilicus 300 32.4% (29.435.4)
Hairlineumbilicus 293 31.7% (28.734.7)
Axillahairline 267 28.8% (25.931.8)
Three-site
Groinnosethroat 850 92% (90.193.6)
Noseperineumthroat 840 91% (88.992.7)
Groinperineumthroat 783 84.6% (82.387)
Groinnoseperineum 769 83.1% (80.785.5)
Grointhroatumbilicus 752 81.3% (78.883.8)
Nosethroatumbilicus 742 80.2% (77.682.8)
Axillagrointhroat 732 79.1% (76.581.7)
Groinhairlinethroat 726 78.5% (75.881.1)
Groinnoseumbilicus 724 78.3% (75.681)
Perineumthroatumbilicus 720 77.8% (75.280.5)
Noseperineumumbilicus 719 77.7% (7580.4)
Axillanosethroat 717 77.5% (74.880.2)
Groinhairlinenose 708 76.5% (73.879.3)
Hairline perineumthroat 706 76.3% (73.679)
Axillaperineumthroat 703 76% (73.278.7)
Hairlinenoseperineum 698 75.5% (72.778.2)
Axillanoseperineum 694 75% (72.277.8)
Axillagroinnose 693 74.9% (72.177.7)
Hairlinenosethroat 690 74.6% (71.877.4)
Axillanoseumbilicus 604 65.3% (62.268.4)
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used nasal swab. This may be useful where nasal, throat, or
perineum swabs cannot be taken for medical or personal
reasons. In addition, the numbers of patients in this study
are relatively high. It would be useful to have further
studies, assessing all seven anatomical sites, similar to this
one in high-risk patients using rapid molecular methodol-
ogies. These molecular methods can be commercial or in-
house (1113). This would allow a faster turn-around time
of results and allow appropriate decolonisation procedures
and infection control measures to be implemented more
rapidly. Although there have been studies showing the
merits of universal decolonisation in intensive care units,
these cannot be used for all areas of healthcare and it
remains important to screen for MRSA in most institu-
tions because of the risks of infection and transmission
(1419). Because screening is relatively expensive, it is
important to determine the optimal and most cost-
effective combination of anatomical sites that are tested.
Our results indicate that a three-site screen, preferably
including groin, nose, and throat will detect the vast
majority of cases. The sensitivity of all other possible
combinations is also presented. We feel that the results of
this study will help healthcare managers to decide the
optimal strategy that can be adopted to optimise the
ability to detect MRSA colonisation and prevent infection
and nosocomial transmission in this at-risk population.
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